Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of albendazole cream in China. Welcome to wholesale bulk high quality albendazole cream for sale here from our factory. Good service and reasonable price are available.
Albendazole cream is a topical antiparasitic formulation designed to treat cutaneous infections caused by parasitic larvae, such as those seen in cutaneous larva migrans, where the active ingredient, albendazole, exerts its effect by disrupting microtubule polymerization in the parasites, leading to impaired energy metabolism and subsequent paralysis and death. This localized treatment minimizes systemic absorption, allowing targeted action on the affected skin areas while reducing the risk of broader pharmacological effects.
At the same time, our company not only provides pure powders, but also tablets and suspension. If needed, please feel free to contact us at any time.
Our Products
Albendazole Powder
Albendazole Tablets
Albendazole Suspension
|
|
|
Albendazole COA
The breakthrough in nanocarrier technology for cream penetration of the stratum corneum
Albendazole cream, as a broad-spectrum antiparasitic drug, its oral formulation is often limited in local treatment due to issues such as low bioavailability and significant first-pass effect. In recent years, the breakthrough in nanocarrier technology has provided an innovative solution for the penetration of albendazole cream through the stratum corneum barrier. By regulating the drug delivery pathway and release kinetics, its local efficacy and safety have been significantly improved.
The cream is typically applied in a thin layer over the infected region two to three times daily for several days, often accompanied by protective bandaging to prevent further larval migration or secondary contamination. Mild dermatological reactions, including transient erythema or irritation, may occur at the application site, though significant adverse effects are rare due to limited systemic exposure. Contraindications include application near mucous membranes or open wounds, and its use should be discontinued if signs of hypersensitivity develop. Albendazole cream provides an effective and convenient option for managing superficial parasitic infestations without the need for systemic drug administration.
Keratin Layer Barrier: The Natural Obstacle of Traditional Delivery Systems
The keratin layer is the outermost layer of the skin, composed of 15-20 layers of keratinocytes and a lipid matrix rich in ceramides and cholesterol, forming a dense "brick wall structure". Its physical barrier function makes molecules with a molecular weight greater than 500 Da difficult to penetrate, while albendazole has a molecular weight of 265.3 Da, although it is close to the critical value, its strong hydrophobicity (logP = 2.7) leads to an imbalance in the distribution coefficient in the keratin layer lipid, and only about 3%-5% of the drug can penetrate the keratin layer and enter the active epidermal layer in traditional cream formulations. In addition, the burst release effect of traditional preparations is prone to cause local irritation, limiting the possibility of high-concentration administration.
Nanocarrier Technology: Three Mechanisms for Breaking Barriers
Size Effect and Surface Modification for Optimizing Permeation Pathways
Nanocarriers can selectively utilize the intercellular pathway between keratinocytes or the follicular appendage pathway for penetration by controlling particle size (10-200 nm) and surface charge. For instance, flexible liposomes (Transferosomes) with their highly elastic membrane structure can achieve "squeezing-type" penetration through the hydrated channels between keratinocytes (with a diameter of approximately 30-50 nm); while magnetic nanoparticles (such as Fe₃O₄@SiO₂) can be guided by an external magnetic field to penetrate the follicular opening and deliver the drug to the dermis.
Construction of gradient release system using biphasic carriers
The nanostructured lipid carrier (NLC) is formed by mixing solid lipids (such as Compritol 888 ATO) with liquid oils (such as Miglyol 812), resulting in an irregular crystal structure that can carry 15%-20% of albendazole. Its core advantage lies in:
Solubility enhancement: The liquid oil phase can dissolve crystalline drugs, increasing the drug loading capacity by 3 times compared to traditional liposomes.
Sustained-release effect,The solid lipid matrix delays drug release, with a cumulative release rate of 85% over 24 hours, while free drugs are completely released within 4 hours;Targeted enrichment: After modifying the surface of NLC with hyaluronic acid, it can specifically bind to the CD44 receptor on the surface of dermal fibroblasts, increasing the drug concentration at the inflammatory site by 12 times.
Co-delivery strategy for multi-target synergy
The anti-parasitic effect of albendazole depends on inhibiting the polymerization of microtubules in parasites, but local infections often accompany inflammatory responses and tissue repair requirements. Nanocarriers can co-load anti-inflammatory components (such as dexamethasone phosphate sodium) and pro-repair factors (such as epidermal growth factor), achieving programmed release through pH-sensitive polymers (such as Eudragit L100-55): it releases albendazole preferentially in acidic inflammatory environments (release rate > 90% at pH 5.5), and then releases growth factors in the neutral repair period. Animal experiments show that the co-delivery system increases the parasite clearance rate to 92% and accelerates wound healing by 40%.
Clinical Value of Technological Breakthroughs
Expand the range of indications
The nanocarrier technology has enabled albendazole to expand its application from traditional parasite infection treatment to the field of skin tumors. For instance, the poly(lactic-co-glycolic acid) (PLGA) nanoparticles carrying albendazole can inhibit the dynamic balance of microtubules in tumor cells and induce the mitochondrial apoptotic pathway. The inhibition rate for basal cell carcinoma reaches 78%, and the cytotoxicity to normal keratinocytes is reduced by 90%.
Enhancing patient compliance
The sustained-release property of the nano-cream enables once-daily administration, significantly improving treatment compliance compared to traditional formulations (which require 3-4 administrations per day). Additionally, the cold compress effect of the flexible liposomes can alleviate itching symptoms, and patient satisfaction has increased from 62% to 89%.
Reduction of Systemic Toxicity
The liver first-pass effect of traditional oral albendazole leads to a bioavailability of only 5%-10%, and may cause side effects such as elevated transaminases and bone marrow suppression. The nano-carriers maintain the drug concentration within the therapeutic window through local administration, reducing the blood drug concentration by 80% compared to oral administration. The incidence of liver toxicity has decreased from 12% to 1.5%.
Future Prospects
With the rapid advancement of materials science and nanotechnology, intelligent responsive nano-carriers-such as temperature-sensitive and light-sensitive hydrogels-are poised to further optimize the precision and controllability of topical drug release systems. For example, the near-infrared light-triggered gold nanorods-albendazole complex represents a cutting-edge innovation in photothermal controlled-release technology, enabling "on-demand release" precisely at the lesion site. This targeted activation not only minimizes systemic absorption and side effects but also significantly increases the local drug utilization rate, achieving an impressive level exceeding 95%. Such a high degree of precision ensures that the therapeutic agent is delivered exactly where and when it is needed, enhancing both safety and efficacy in clinical applications.
By fundamentally reconfiguring the drug delivery pathway, nano-carrier technology has not only overcome the longstanding penetration barriers associated with conventional albendazole cream-such as inadequate transdermal absorption and poor bioavailability-but has also established a pioneering model for the cross-sector integration of antiparasitic pharmacotherapy and functional cosmetics.
This interdisciplinary convergence exemplifies how pharmaceutical innovation can expand into new domains, offering multifunctional benefits that extend beyond traditional treatment paradigms. As clinical data continues to accumulate and industrialization costs gradually decrease through technological maturation and economies of scale, it is highly anticipated that by 2030, such intelligent nano-enabled delivery systems will become a standard configuration in the field of topical therapeutics, revolutionizing the management of both parasitic skin infections and broader dermatological disorders.
The problem of oxidative failure in bulk packaging in tropical regions
In tropical regions, the combined effect of high temperature, high humidity and strong ultraviolet radiation significantly accelerates the oxidation failure process of the tube packaging of albendazole cream. This phenomenon involves multiple mechanisms such as degradation of the drug components, deterioration of the packaging material properties, and an increase in the risk of microbial contamination. A systematic analysis needs to be conducted from the aspects of chemical stability, packaging material characteristics, and environmental adaptability.
Oxidative Degradation Mechanism of Drug Components
The sulfur ether group (-S-) and amide ester bond (-NH-COO-) in the molecular structure of albendazole are highly sensitive to oxidation reactions. In tropical regions, high temperatures (typically > 30°C) increase the thermal motion energy of the molecules, making the sulfur ether group more susceptible to attack by oxygen, generating sulfoxide-type intermediates with phototoxicity. These intermediates further oxidize into sulfone compounds under ultraviolet (UV-A/UV-B) irradiation, resulting in a decrease in the content of the active drug components. Experimental data show that after being stored at 40°C/75%RH for 6 months, the degradation rate of the active components in albendazole cream can reach 15%-20%, which is much higher than 5%-8% under room temperature conditions.
Oxidative Degradation of Pipe Packaging Materials
Traditional aluminum-plastic composite pipes or polyethylene (PE) pipes face two challenges in tropical environments:
Barrier performance degradation
High temperatures reduce the crystallinity of packaging materials, increasing the oxygen transmission rate (OTR) by 30% - 50%. For example, the OTR of unmodified PE pipes at 23°C is 20 cm³/(m²·24h·0.1MPa), while it can increase to 35 cm³/(m²·24h·0.1MPa) at 40°C, allowing more oxygen to penetrate into the cream.
Additive migration
To enhance flexibility, packaging materials often contain plasticizers (such as phthalate esters). High temperatures accelerate the migration of these small molecule additives to the surface of the cream, not only contaminating the drug but also potentially altering the rheological properties of the cream (such as a 10% - 15% decrease in viscosity), affecting the uniformity of extrusion.
Catalytic effect of microbial contamination
The high humidity in tropical regions (typically > 80% RH) provides ideal conditions for microbial proliferation. The sulfoxide compounds produced by oxidative degradation have surfactant properties, which can disrupt the emulsification structure of the cream, release bound water, and increase the water activity (Aw) from 0.45 to 0.60. This change significantly promotes the growth of aerobic bacteria (such as Pseudomonas aeruginosa) and molds (such as Aspergillus niger). The reactive oxygen species (ROS) produced by microbial metabolism, such as hydrogen peroxide and superoxide, will further accelerate the oxidative degradation of albendazole, creating a vicious cycle.
Solutions and Technological Breakthroughs
Antioxidant Combinatorial System
By using the synergistic combination of vitamin E (α-tocopherol) and BHT (2,6-dibutyl-4-methylphenol), the induction period of the cream at 40°C can be extended (from 15 days to 45 days), and the degradation rate within 6 months can be controlled within 10%.
High Barrier Packaging Materials
The oxygen barrier property of ethylene-vinyl alcohol copolymer (EVOH) is 1000 times that of PE. Using the five-layer co-extrusion technology of EVOH/PE to prepare the composite tube, the OTR can be reduced to below 0.5 cm³/(m²·24h·0.1MPa), significantly delaying the oxidation process.
Cold Chain Replacement Solution
In regions lacking refrigeration conditions, phase change materials (PCM) packaging, such as paraffin-based microcapsules, can be adopted. Such materials undergo solid-liquid phase change above 30°C, absorbing heat and maintaining the internal temperature of the tube ≤ 28°C, thereby reducing the degradation rate of the drug by 60%-70%.
Hot Tags: albendazole cream, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale